1H-Indole-3-carboxylicacid, octahydro-3-hydroxy-2,6-methano-2H-quinolizin-8-yl ester (127951-99-9)

Identification
Name:	1H-Indole-3-carboxylicacid, octahydro-3-hydroxy-2,6-methano-2H-quinolizin-8-yl ester
Synonyms:	2,6-Methano-2H-quinolizine,1H-indole-3-carboxylic acid deriv.; Hydrodolasetron; MDL 74156; Reduceddolasetron
CAS:	127951-99-9
Molecular Formula:	C19H22 N2 O3
Molecular Weight:	326.3896
InChI:	InChI=1/C19H22N2O3/c22-18-10-21-12-5-11(18)6-13(21)8-14(7-12)24-19(23)16-9-20-17-4-2-1-3-15(16)17/h1-4,9,11-14,18,20,22H,5-8,10H2
Molecular Structure:
Properties
Flash Point:	277.2°C
Boiling Point:	534.7°Cat760mmHg
Density:	1.37g/cm³
Refractive index:	1.685
Flash Point:	277.2°C
Safety Data

Other Product

1H-Indole-3-carboxylicacid, octahydro-3-oxo-2,6-methano-2H-quinolizin-8-yl ester, stereoisomer
6-[8-hydroxy-1-(hydroxymethyl)octahydro-2H-quinolizin-3-yl]piperidin-2-one
10H-3,8a-Methano-1H-azepino[1',2':1,2]pyrrolo[2,3-b]indole-14-carboxylicacid,4-ethylidene-2,3,4,5,7,8-hexahydro-11-[(2R,3S,5S,7aR,12aR,12bS,13S)-1,3,4,6,7,12,12a,12b-octahydro-3-[(1R)-1-hydroxyethyl]-10-methoxy-12-methyl-14-oxo-2H-3,2,7a-(epoxyethanylylidene)indolo[2,3-a]quinolizin-9-yl]-10-oxo-,methyl ester, (3R,4E,6S,8aR,13aR,14S)- (9CI)
2,6-Methano-2H-quinolizin-3(4H)-one,hexahydro-8-hydroxy-
2,6-Methano-1H-azecino[5,4-b]indole-14-carboxylicacid, 3-acetyl-5-ethylidene-2,3,4,5,6,7,8,9-octahydro-8-oxo-, methyl ester
2(1H)-Pyridinone,6-[(1R,3S,9aS)-octahydro-1-(hydroxymethyl)-2H-quinolizin-3-yl]-, rel-(+)-
Spiro[5H-1,4-epoxy-2,7-methano-2H-3,1-benzoxazine-5,3'-[3H]indole]-6-carboxylicacid, 8-ethylidene-1',2',4,4a,6,7,8,8a-octahydro-2'-oxo-, methyl ester,(1S,2R,3'R,4R,4aS,6R,7R,8E,8aS)- (9CI)
Benzenepropanal,4-hydroxy-3-[2-methoxy-6-[(2S,4S,9aR)-octahydro-2-hydroxy-2H-quinolizin-4-yl]phenoxy]-
Yohimban-16-carboxylicacid,21-[(2S,3R,12bS)-3-ethyl-1,2,3,4,6,7,12,12b-octahydro-8-hydroxy-2-[(1E)-2-methoxy-1-(methoxymethylene)-2-oxoethyl]indolo[2,3-a]quinolizin-9-yl]-17-hydroxy-,methyl ester, (3b,16b,17b,21b)- (9CI)
Yohimban-16-carboxylicacid,21-[(2S,3R,12bS)-3-ethyl-1,2,3,4,6,7,12,12b-octahydro-8-hydroxy-2-[(1E)-2-methoxy-1-(methoxymethylene)-2-oxoethyl]indolo[2,3-a]quinolizin-9-yl]-17-hydroxy-,methyl ester, (3b,16a,17b,21b)- (9CI)
Yohimban-16-carboxylicacid,21-[(2S,3R,12bS)-3-ethyl-1,2,3,4,6,7,12,12b-octahydro-8-hydroxy-2-[(1E)-2-methoxy-1-(methoxymethylene)-2-oxoethyl]indolo[2,3-a]quinolizin-9-yl]-17-hydroxy-,methyl ester, (3b,16a,17a,21b)- (9CI)
1H-Indole-2-carboxylicacid, 6-chloro-3-hydroxy-, ethyl ester
Yohimban-16-carboxylicacid,21-[(2S,3R,12bS)-3-ethyl-1,2,3,4,6,7,12,12b-octahydro-8-hydroxy-2-[(1E)-2-methoxy-1-(methoxymethylene)-2-oxoethyl]indolo[2,3-a]quinolizin-10-yl]-9,17-dihydroxy-,methyl ester, (3b,16a,17a,21b)- (9CI)
Methanone, (octahydro-2H-quinolizin-3-yl)phenyl-
(Octahydro-2H-quinolizin-3-yl)di(2-thienyl)methanol
Methanone, (octahydro-2H-quinolizin-3-yl)-2-thienyl-, trans-
2,6-Methano-2H-quinolizin-3(4H)-one,hexahydro-8-hydroxy-, stereoisomer
Hexahydro-8-hydroxy-2,6-Methano-2H-quinolizin-3(4H)-one Hydrochloride Salt
Endo-hexahydro-8-hydroxy-2,6-methano-2H-quinolizin-3(4H)-one mesylate
4-Quinazolinamine,N-(3,4-dichloro-2-fluorophenyl)-6-methoxy-7-[(octahydro-2H-quinolizin-3-yl)methoxy]-